97 related articles for article (PubMed ID: 9021902)
1. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
Engberg G; Elverfors A; Jonason J; Nissbrandt H
Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux.
Nissbrandt H; Elverfors A; Engberg G
Synapse; 1994 Aug; 17(4):217-24. PubMed ID: 7992197
[TBL] [Abstract][Full Text] [Related]
3. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
Engberg G; Kling-Petersen T; Nissbrandt H
Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
[TBL] [Abstract][Full Text] [Related]
4. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity.
Smith ID; Grace AA
Synapse; 1992 Dec; 12(4):287-303. PubMed ID: 1465742
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.
Shahabi HN; Andersson DR; Nissbrandt H
Synapse; 2008 May; 62(5):379-88. PubMed ID: 18288650
[TBL] [Abstract][Full Text] [Related]
6. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
[TBL] [Abstract][Full Text] [Related]
7. [The effect of the dopamine neuronal reuptake inhibitor GBR 12909 on the dopaminergic neurotransmission parameters in the rat striatum in vivo].
Budygin EA; Kilpatrick M; Gaĭnetdinov RR; Raevskiĭ KS; Wightman RM
Eksp Klin Farmakol; 1999; 62(5):3-6. PubMed ID: 10572741
[TBL] [Abstract][Full Text] [Related]
8. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
Pucak ML; Grace AA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
[TBL] [Abstract][Full Text] [Related]
10. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
[TBL] [Abstract][Full Text] [Related]
11. Effects of scopolamine on dopamine neurons in the substantia nigra: role of the pedunculopontine tegmental nucleus.
Di Giovanni G; Shi WX
Synapse; 2009 Aug; 63(8):673-80. PubMed ID: 19360852
[TBL] [Abstract][Full Text] [Related]
12. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
Lee CR; Abercrombie ED; Tepper JM
Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
[TBL] [Abstract][Full Text] [Related]
13. Reverse microdialysis of a dopamine uptake inhibitor in the nucleus accumbens of alcohol-preferring rats: effects on dialysate dopamine levels and ethanol intake.
Engleman EA; McBride WJ; Wilber AA; Shaikh SR; Eha RD; Lumeng L; Li TK; Murphy JM
Alcohol Clin Exp Res; 2000 Jun; 24(6):795-801. PubMed ID: 10888067
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity.
Lodge DJ; Grace AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):201-6. PubMed ID: 15784652
[TBL] [Abstract][Full Text] [Related]
15. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
Heidenreich BA; Rebec GV
Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
[TBL] [Abstract][Full Text] [Related]
16. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
17. Effects of electrical stimulation of the central nucleus of the amygdala on the in vivo electrophysiological activity of rat nigral dopaminergic neurons.
Rouillard C; Freeman AS
Synapse; 1995 Dec; 21(4):348-56. PubMed ID: 8869165
[TBL] [Abstract][Full Text] [Related]
18. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
19. Competitive NMDA receptor antagonists differentially affect dopamine cell firing pattern.
Connelly ST; Shepard PD
Synapse; 1997 Mar; 25(3):234-42. PubMed ID: 9068121
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro.
Werkman TR; Olijslagers JE; Perlstein B; Jansen AH; McCreary AC; Kruse CG; Wadman WJ
Eur J Pharmacol; 2004 Dec; 506(1):47-53. PubMed ID: 15588623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
